ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1884

Disease Activity in an Axial Spondyloarthritis Cohort During the COVID-19 Pandemic

Jean Liew1, Maria Castillo2, Ethan Zaccagnino2, Patricia Katz3, Nigil Haroon4 and Lianne Gensler5, 1University of Washington, Seattle, WA, 2UCSF, San Francisco, CA, 3University of California, San Francisco, Novato, CA, 4University of Toronto, Toronto, ON, Canada, 5University of California San Francisco, San Francisco, CA

Meeting: ACR Convergence 2020

Keywords: Ankylosing spondylitis (AS), COVID-19, spondyloarthritis, Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: Axial SpA

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Response to the global coronavirus disease (COVID-19) pandemic has resulted in shelter-in-place orders and major changes to how people go about their daily lives. The impact of such stressors on disease activity in individuals with axial spondyloarthritis (axSpA) is unclear. The primary aim of this study is to examine whether stress and anxiety are associated with disease activity, after accounting for important factors.

Methods: We administered a survey to an axSpA cohort from a single center with well-defined demographic and disease characteristics. The survey included questions about changes in job status, exercise, medication use, disease activity (by the Bath Ankylosing Spondylitis Disease Activity Index [BASDAI]), and psychological factors (stress, depressive symptoms, and anxiety). Two separate multivariable linear models examined the associations between perceived stress with BASDAI, and anxiety with BASDAI.

Results: After adjustment for potential confounders, those with higher levels of stress had a statistically significant 0.54-point higher BASDAI, on average, compared to those with lower levels of stress (95% confidence interval [CI] 0.11, 0.97). Those with higher levels of anxiety also had a statistically significant higher BASDAI, on average, compared to those with lower levels of anxiety (β 0.95, 95% CI 0.18, 0.99). We did not find differences in these associations among subgroups of age, job status, or county of residence.

Conclusion: Individuals with axSpA with higher levels of stress and anxiety had significantly higher disease activity levels. Further studies are needed to evaluate the trajectory of disease activity as the pandemic continues to evolve.

Table 1. Baseline characteristics for survey respondents (n=203) stratified by Perceived Stress Scale score


Disclosure: J. Liew, None; M. Castillo, None; E. Zaccagnino, None; P. Katz, None; N. Haroon, Amgen, 1, Eli Lilly, 1, Novartis, 1, Janssen, 1, UCB, 1; L. Gensler, AbbVie, 5, GlaxoSmithKline, 5, Eli Lilly, 5, Novartis, 2, 5, Pfizer, 2, 5, UCB Pharma, 2, 5.

To cite this abstract in AMA style:

Liew J, Castillo M, Zaccagnino E, Katz P, Haroon N, Gensler L. Disease Activity in an Axial Spondyloarthritis Cohort During the COVID-19 Pandemic [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/disease-activity-in-an-axial-spondyloarthritis-cohort-during-the-covid-19-pandemic/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/disease-activity-in-an-axial-spondyloarthritis-cohort-during-the-covid-19-pandemic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology